BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37891932)

  • 1. Quinoline Derivatives: Promising Antioxidants with Neuroprotective Potential.
    Hernández-Ayala LF; Guzmán-López EG; Galano A
    Antioxidants (Basel); 2023 Oct; 12(10):. PubMed ID: 37891932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design of Multifunctional Ferulic Acid Derivatives Aimed for Alzheimer's and Parkinson's Diseases.
    Guzmán-López EG; Reina M; Hernández-Ayala LF; Galano A
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors.
    Pérez-González A; Castañeda-Arriaga R; Guzmán-López EG; Hernández-Ayala LF; Galano A
    ACS Omega; 2022 Nov; 7(43):38254-38268. PubMed ID: 36340167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CADMA-Chem: A Computational Protocol Based on Chemical Properties Aimed to Design Multifunctional Antioxidants.
    Guzman-Lopez EG; Reina M; Perez-Gonzalez A; Francisco-Marquez M; Hernandez-Ayala LF; Castañeda-Arriaga R; Galano A
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of catechol O-methyltransferase and monoamine oxidase by tetralone and indanone derivatives substituted with the nitrocatechol moiety.
    de Beer AD; Legoabe LJ; Petzer A; Petzer JP
    Bioorg Chem; 2021 Sep; 114():105130. PubMed ID: 34225162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.
    Hitge R; Smit S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127188. PubMed ID: 32299731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting caffeic acid performance as antioxidant and monoamine oxidase B/catechol-O-methyltransferase inhibitor.
    Chavarria D; Benfeito S; Soares P; Lima C; Garrido J; Serrão P; Soares-da-Silva P; Remião F; Oliveira PJ; Borges F
    Eur J Med Chem; 2022 Dec; 243():114740. PubMed ID: 36116233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
    Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
    Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
    Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
    ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
    Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
    Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation.
    Anastassova N; Aluani D; Kostadinov A; Rangelov M; Todorova N; Hristova-Avakumova N; Argirova M; Lumov N; Kondeva-Burdina M; Tzankova V; Yancheva D
    Neural Regen Res; 2021 Nov; 16(11):2299-2309. PubMed ID: 33818516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
    Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
    Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2019; 19(2):133-145. PubMed ID: 31258092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.
    Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y
    Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computationally Designed Sesamol Derivatives Proposed as Potent Antioxidants.
    Castro-González LM; Alvarez-Idaboy JR; Galano A
    ACS Omega; 2020 Apr; 5(16):9566-9575. PubMed ID: 32363309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory potential of plant secondary metabolites on anti-Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural abnormalities.
    Mazumder MK; Borah A; Choudhury S
    Med Hypotheses; 2020 Apr; 137():109544. PubMed ID: 31954292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.